| APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions S Thakur, B Sarkar, RP Cholia, N Gautam, M Dhiman, AK Mantha Experimental & molecular medicine 46 (7), e106-e106, 2014 | 180 | 2014 |
| DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and … G Kaur, RP Cholia, AK Mantha, R Kumar Journal of medicinal chemistry 57 (24), 10241-10256, 2014 | 46 | 2014 |
| Oxidative stress stimulates invasive potential in rat C6 and human U-87 MG glioblastoma cells via activation and cross-talk between PKM2, ENPP2 and APE1 enzymes RP Cholia, M Dhiman, R Kumar, AK Mantha Metabolic Brain Disease 33, 1307-1326, 2018 | 21 | 2018 |
| Understanding the multifaceted role of ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2) and its altered behaviour in human diseases R P Cholia, H Nayyar, R Kumar, A K Mantha Current Molecular Medicine 15 (10), 932-943, 2015 | 18 | 2015 |
| An in vitro study ascertaining the role of H2O2 and glucose oxidase in modulation of antioxidant potential and cancer cell survival mechanisms in glioblastoma U … RP Cholia, S Kumari, S Kumar, M Kaur, M Kaur, R Kumar, M Dhiman, ... Metabolic Brain Disease 32, 1705-1716, 2017 | 16 | 2017 |
| A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme H Verma, RP Cholia, S Kaur, M Dhiman, AK Mantha Metabolic Brain Disease 36, 751-765, 2021 | 13 | 2021 |
| Anticancer activity of dihydropyrazolo[1,5‐c]quinazolines against rat C6 glioma cells via inhibition of topoisomerase II G Kaur, RP Cholia, G Joshi, SM Amrutkar, S Kalra, AK Mantha, ... Archiv der Pharmazie 351 (6), 1800023, 2018 | 12 | 2018 |
| Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation FX Scarlett Acklin, Ratan Sadhukhan, Wuying Du, Mousumi Patra, Ravi Cholia Neuro-Oncology Advances 4 (1), 1-12, 2022 | 2* | 2022 |
